Evidence map›Paper›PMID 32291391›Full record

ArticleBritish journal of cancer2020

The association between unexpected weight loss and cancer diagnosis in primary care: a matched cohort analysis of 65,000 presentations.

Brian D Nicholson, Willie Hamilton, Constantinos Koshiaris, Jason L Oke, F D Richard Hobbs, Paul Aveyard

Registry-linked trialAbstract read
In one paragraph

Article in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05876676 (Rapid Diagnostic Centre Biomarker Study), which is not on this map. Cited by 38 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05876676 recruitingnot on this mapstarted 2023, after this paper: background citation

Rapid Diagnostic Centre Biomarker Study

Typeobservational_patient_registrySponsorRoyal Marsden NHS Foundation TrustRan2023 to 2032Enrolled1,000ConditionsCancer
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Diagnostic Risk Prediction Models for Upper Gastrointestinal Cancers: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brian D NicholsonNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK. brian.nicholson@phc.ox.ac.uk.ORCID http://orcid.org/0000-0003-0661-7362
Willie HamiltonMedical School, University of Exeter, Exeter, UK.
Constantinos KoshiarisNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.ORCID http://orcid.org/0000-0002-9821-7608
Jason L OkeNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.
F D Richard HobbsNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.
Paul AveyardNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Funding

Cancer Research UK C8640/A23385Department of Health DRF-2015-08-185
6 · The paper itself

Abstract

backgroundWe aimed to understand the time period of cancer diagnosis and the cancer types detected in primary care patients with unexpected weight loss (UWL) to inform cancer guidelines.

methodsThis retrospective matched cohort study used cancer registry linked electronic health records from the UK's Clinical Practice Research Datalink from between 2000 and 2014. Univariable and multivariable time-to-event analyses examined the association between UWL, and all cancers combined, cancer site and stage.

resultsIn all, 63,973 patients had UWL recorded, of whom 1375 (2.2%) were diagnosed with cancer within 2 years (days-to-diagnosis: mean 181; median 80). Men with UWL (HR 3.28 (2.88-3.73)) and women (1.87 (1.68-2.08)) were more likely than comparators to be diagnosed with cancer within 3 months. The association was greatest in men aged ≥50 years and women ≥70 years. The commonest cancers were pancreas, cancer of unknown primary, gastro-oesophageal, lymphoma, hepatobiliary, lung, bowel and renal-tract. The majority were late-stage, but there was some evidence of association with stage II and stage III cancers. In the 3-24 months after presenting with UWL, cancer diagnosis was less likely than in comparators.

conclusionUWL recorded in primary care is associated with a broad range of cancer sites of early and late-stage.

Indexed as

NeoplasmsWeight LossAdolescentAdultAgedAged, 80 and overCohort StudiesElectronic Health RecordsFemaleHumansMaleMiddle AgedPrimary Health CareRetrospective StudiesRisk FactorsUnited Kingdom

Identifiers

PMID32291391
PMCPMC7283307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.